Frits, chemicals

Carcinogenicity

Description of key information

ORAL: Data are read-across from Ni sulfate as Ni sulfate represents a worst case scenario for oral absorption of nickel. A well-conducted OECD 451 study in rats did not show any carcinogenic potential of nickel sulphate following oral administration. A summary document on this topic can be found in the attached document entitled, " Background-Oral Carcinogenicity for all Nickel Compounds" (Section 7.7 of IUCLID) and in Appendix B5 of the CSR.

INHALATION: The most robust and environmentally relevant carcinogenicity study for NiO was conducted as part of a National Toxicology Program study on the toxicity and carcinogenicity of NiSO4, Ni3S2 and NiO (Dunnick et al. 1995). Following inhalation of NiO for up to two years (6 hr/d, 5 d/wk, two exposure levels), the authors characterized the evidence for lung tumor formation in rats as “some” as opposed to “no” or “clear.” In mice, the authors characterized the evidence for NiO carcinogenicity in the lung as "equivocal." Taken together the epidemiological and animal data suggest that at least some forms of nickel oxide can be carcinogenic to the respiratory tract of humans after inhalation.

DERMAL: Read-across from Ni sulfate. As oral exposure to nickel sulphate does not show any carcinogenic potential, there are good reasons to assume that cancer is not a relevant end-point with respect to dermal exposure either.

Key value for chemical safety assessment

Carcinogenicity: via inhalation route

Endpoint conclusion

Dose descriptor:

NOAEC

0.62 mg/m³

Justification for classification or non-classification

Ni oxide is classified for carcinogenicity via inhalation (Carc. 1A:H350i) according to the 1st ATP to the CLP Regulation. Supporting information can be found in the discussion section for this endpoint.

Additional information

Data on the oral carcinogenicity of Ni oxide are read-across from Ni sulfate as Ni sulfate represents a worst case scenario for oral absorption of nickel.

ENDPOINT SUMMARY INFORMATION FROM THE 2008/2009 EU NICKEL SULPHATE RISK ASSESSMENT: 

The carcinogenicity of nickel sulphate following oral administration has been studied in two old non-guideline studies with rats and dogs; no neoplasms were revealed in either rats or dogs in these studies. A 2-year carcinogenicity study with rats performed according to OECD 451 did not show any carcinogenic potential of exposure to nickel sulphate following oral (gavage) administration. Data on other nickel compounds are limited to a drinking water study of nickel acetate in rats and mice in which no exposure-related neoplasms was observed. In conclusion, there is sufficient oral carcinogenicity data to show that nickel sulphate does not show any carcinogenic potential in experimental animals following oral administration.

In addition, a background document summarizing the potential of Ni compounds to cause cancer via the oral route of exposure can be found in the attached document entitled, " Background-Oral Carcinogenicity for all Nickel Compounds" (Section 7.7) and inAppendix B6of this CSR.

The carcinogenicity of various nickel oxides has been examined following intramuscular (i. m.), intraperitoneal (i. p.), intrapleural, inhalation, and intratracheal instillation routes of exposure. For all routes except inhalation, exposure was acute or subchronic (i. e., one or two doses, or once/week for 5 to 15 weeks, respectively), whereas for inhalation, a two-year, chronic exposure study with high calcining temperature (green) nickel oxide was identified. Studies have generally utilized rats, though two studies evaluating carcinogenicity in mice were also identified. With the exception of two studies, all studies evaluated only a single dose of nickel oxide, and only three studies identified the type of nickel oxide assessed. NiO exists as a range of compounds from a high-temperature (green) variety to a low-temperature (jet-black) product. Thermal history is the main factor that determines the color, reactivity and stoichiometric proprtions of nickel and oxygen in the resulting oxide (Van Vlack, 1980).

Studies in rodents demonstrated that NiO (unspecified color) was carcinogenic following a single i. m. injection of 5 mg in mice and 20 mg in Wistar rats (Gilman, 1962). The majority of these tumors were sarcomas that showed propensity to metastasize to the lungs in rats but less so in mice. Similar results were reported by Sunderman (1984), where i. m. injection of green-grey NiO (14 mg Ni/rat) induced sarcomas in 14/15 F344 rats (52% of these tumors were rhabdomyosarcomas). In a later study, Sunderman et al. (1990) examined the carcinogenicity of three forms of nickel oxide calcined at different temperatures (black, grey-black, and green) following a single i. m. administration of NiO (dose based on concentration of nickel, 20 mg Ni/rat). Only rats exposed to black (low calcining temperature) NiO exhibited sarcomas at the injection site. Similar dose levels were shown to induce sarcomas in rats following a single intrapleural injection of 10 mg NiO (unspecified color/temperature) (Skaug et al., 1985). Pott et al. (1987) reported that i. p. injection of a maximum tolerable dose of 1000 mg NiO (split between two weekly administrations) of unspecified color resulted in tumor formation in 98% of 47 Wistar rats within an average latency period of 31 weeks. This group of researchers also evaluated carcinogenicity in rats following intratracheal administration (10 mg NiO, unspecified color) in Wistar rats once weekly for 5 or 15 consecutive weeks. Approximately 30% of the animals in each dose group (total dose of 50 or 150 mg NiO) exhibited tumors in the lung and trachea. It is worth noting that this is not considered a relevant route of exposure for NiO compounds.

The route of exposure of most relevance to humans is inhalation, and thus the most robust and applicable study for characterizing carcinogencity associated with chronic exposure was that reported by Dunnick and colleagues (1995), in which the findings of a 2 -year bioassay conducted by the National Toxicology Program were reported (NTP, 1996). These authors reported that inhalation of a high-calcining temperature (green) NiO caused lung neoplasms in F344 rats and B6C3F1 mice exposed chronically (two years) for 6 hr/day (3 dose groups tested in both species). In rats, adenomas and carcinomas were observed in the lungs of both male and female rats at concentrations ≥ 1.25 mg/m³(a statistically significant increase in tumors was not observed at 0.62 mg/m³), and pheochromocytomas at the highest dose of 2.5 mg/m³NiO. In B6C3F1 mice, adenomas and carcinomas were observed only in females at 2.5 mg/m³but not at 5.0 mg/m³(a statistically significant increase in tumors was not observed at 1.25 mg/m³), thus demonstrating a lack of dose-response relationship in mice. No other exposure-related neoplasms were found in rats or mice. Based on these collective findings, the authors characterized the evidence for lung tumor formation and adrenal medullary tumors in rats as “some” as opposed to “no” or “clear. ”The induction of lung tumors in rats may have been at least in part do to a “particle overload” effect, since impaired lung clearance was noted at the highest exposure levels (Oller et al., 1997).  In mice, the authors characterized the evidence for NiO carcinogenicity in the lung as “equivocal.” In contrast to these findings, Haratake et al. (1992) did not find any tumorous lesions in rats exposed to 1 mg NiO/m³(black or green) for six months. Following an additional 12-month observation period in which no additional treatment-related tumors were found, the authors concluded that neither green nor black NiO showed any apparent promoting effects on tumorigenesis

Taken together, available carcinogenicity data indicate that nickel oxide compounds have the potential to induce tumors at the point of contact following short-term or long-term exposure. Physiochemical characteristics greatly influence carcinogenic potential, as demonstrated by findings from injection studies indicating that green nickel oxide has less carcinogenic potency than black nickel oxide. Data were sufficient to characterize inhalation carcinogenicity of green nickel oxide in laboratory animals; however, additional data may be needed to fully characterize the carcinogenic potency of black nickel oxides following long term exposure via environmentally relevant routes. At least with regards to lung toxicity, the black and the green forms of nickel oxide behaved similarly in recent acute inhalation studies (EPSL, 2009, 210), demonstrating similar low acute toxicity.

 

The epidemiological evaluation of the carcinogenic risk for different nickel species has some limitations. There are no available cohorts exclusively exposed to a single nickel species. Furthermore, assessments of the relative contribution of the different nickel species far back in time depend largely on 1) more recent exposure measurements that are back extrapolated to earlier times or 2) exposure estimates based on job histories. Both these approaches introduce uncertainty, and comparatively minor differences in estimated exposures may have a high impact on dose-response relationships. While the animal studies described above have been conducted with various forms of nickel monoxide, the exposures of human cohorts are generally described as being to “oxidic nickel.” Oxidic nickel includes low and high calciningrature NiO but can also include nickel hydroxides, nickel carbonates, nickel silicates and complex compounds containing other metals (e.g., nickel-copper oxides).

Several epidemiological studies evaluating the association between occupational exposure to oxidic nickel and disease (primarily lung and nasal cancer) were identified. High risk cohorts with significant oxidic nickel exposures are comprised of workers employed in the processing and refining of sulfidic nickel ores in,, and (Doll et al., 1990; Roberts et al., 1989; Andersen et al., 1996; Grimsrud et al., 2003). Low risk cohorts exposed to oxidic nickel are found among lateritic ores refining workers in (Doll et al., 1990; Goldberg et al., 1994) and alloy workers in the(Enterline and Marsh, 1982; Redmond et al., 1994; Arena et al., 1998). Exposures in all these workers were always mixed, with confounding from other nickel species as well as other metals, acid mists, arsenic and smoking. This was a factor acknowledged by the authors in each study; however, each of these studies specifically identified nickel oxide as a primary compound to which some workers were exposed.

 

The Clydach cohort consisted of 2521 men which were employed in various processes in the refining of nickel from grinding and roasting of nickel containing sulfidic nickel and copper, extraction of copper by sulfuric acid, reduction of oxidic nickel by water gas, extraction of nickel as gaseous nickel carbonyl and decomposition of the carbonyl by heat (Doll et al., 1990). Workers were predominantly exposed to sulfidic, oxidic (mainly Ni-Cu oxides and impure NiO) and metallic nickel dusts and, to a lower extent, to soluble nickel salts in a hydrometallurgical plant. Reliable quantitative data about airborne exposures do not exist, except the fact that exposures had been very high in milling/grinding, roasting and plant cleaning occupations. Average levels of 20 mg/m³of oxidic nickel in the calcining area and of 13 mg/m³in thecopper plant were estimated. There were high incidences of lung and nasal cancers in workers hired prior to 1930 (Doll et al., 1990). This sub-cohort exhibited 172 lung cancer cases with a SMR 393 (95% CI 336-456) and 74 nasal cancers with a SMR 21119 (95% CI 16583-26514).Workers hired after 1940 showed little (if any) increased lung or nasal cancer risk ( Peto et al., 1984; Doll et al., 1990; Sorahan and Williams, 2005). This could be due to the introduction of respiratory protection in some areas of the refinery, reduction in overall dust due to the introduction of improved equipment and changes in the feed material and sulfuric acid. These changes resulted in the elimination of high concentrations of arsenic, copper, and sulfur.  In the Grimsrud and Peto (2006) analyses of the Clydach data, increased nasal and lung cancer risk (30%) for workers hired after 1930 are reported. Men that worked 15 years or longer in the Clydach nickel plant had increased SMRs for lung cancer. As oxidic nickel was the predominant species this suggests that it played a role in carcinogenicity of the nickel plant workers.

In workers from the refinery in, evaluation was conducted for four groups of nickel species. Oxidic nickel could be found mainly in the roasting, smelting and calcining department. Average levels of oxidic nickel (including complex Ni-Cu oxides and NiO) were estimated at 10 mg/m³before 1956 and 5 mg/m³thereafter, with lesser amounts present in certain areas of the refinery. Workers employed in roasting, smelting and calcining department showed a positive relationship between excess cancer risk and duration of exposure, suggesting an association between carcinogenicity and oxidic nickel exposure (Doll et al., 1990). In an update of this cohort, there continued to be some evidence that long term exposure to oxidic nickel was related to an excess lung cancer risk. Importantly this study showed that cigarette smoking in combination with exposure to nickel appears to produce synergistic effects (Andersen et al.,1996). The authors specifically noted that a dose-response relationship was observed for exposure to nickel oxide and nasal cancer, though the lack of direct evaluation of exposure limits the interpretation of this finding (Andersen et al., 1996). In the Grimsrud et al., (2003) analysis of this cohort, increased relative risks of lung cancer were observed with increased cumulative exposure to oxidic nickel after age adjustments, with or without adjustment for smoking.

Ontariosintering workers at the Copper Cliff plant () and the leaching, calcining and sintering department within thenickel refinery were exposed to both oxidic and sulfidic nickel. These workers experienced increased SMRs for lung and nasal cancers (Doll et al., 1990; Roberts et al., 1989).

Workers in New Caledonia smelting and refining lateritic ores showed no association between exposures to nickel (mostly in the forms of silicate oxides or complex oxides devoid of copper) and excess nasal or lung cancer risks (Doll et al., 1990; Goldberg et al., 1996). Highest estimated nickel exposure levels were less than 2 mg/m³.

A large study of high nickel alloy workers in theincluded about 31,000 workers followed until 1988 (Enterline and Marsh, 1982; Redmond et al., 1983; 1984; Arena et al., 1998). Workers were exposed mainly to metallic and oxidic nickel present as complex oxides of iron, nickel, chromium, generally free of copper. Average nickel exposures of these workers were relatively low (0.7 mg/m³) (Sivulka and Seilkop, 2009). A small increase in lung cancer risk was found when the cohort was compared to thepopulation (RR=1.13; 95%CI: 1.05-1.17), but no excess lung cancer risks were found when compared to the local reference populations (RR=1.01; 95%CI: 0.95-1.09).

Exposure to nickel oxide was characterized by Polednak et al (1981) in an evaluation of welders from nuclear facilities in. This study did not find compelling associations between exposure and mortality (primarily due to a large amount of variability around standard mortality rates, SMRs), though the authors concluded that high risks for respiratory cancer associated with nickel oxide exposure could not be excluded. It should be noted that this study applies only to exposures during welding. Welding involves exposure to fine fumes of various metals, asbestos, etc., and thus this study is not relevant for exposures to nickel oxides outside of welding.

Collectively, these studies generally relied on estimates of exposure based on historical industrial hygiene data and/or job exposure matrices. Because it was not possible to determine components of dust or identify the nickel species, it is difficult to state with certainty which specific nickel compounds were associated with the suggested increases in respiratory cancer risk observed in workers with some exposure to nickel oxide. It appears that high risk cohorts had higher levels of exposure to oxidic nickel containing nickel-copper oxides, while low risk cohorts had lower levels of exposure to oxidic nickel devoid of copper. (Nickel-copper oxides have been shown in animal injection studies to have a potency similar to that of nickel subsulfide and much higher potency than NiO, to induce tumors (Sunderman et al., 1990). Therefore, the available epidemiological data characterizing associations between disease and exposure to nickel monoxide do not provide compelling evidence of a causal relationship, though such a relationship can also not be excluded. Stronger evidence is present for exposure to oxidic nickel compounds that include complex Ni-Cu oxides. Taken together the epidemiological and animal data suggest that at least some forms of nickel oxide can be carcinogenic to the respiratory tract of humans after inhalation.

The following information is taken into account for any hazard / risk assessment:

ORAL: Data are read-across from Ni sulphate (highest systemic bioavailability). A well-conducted OECD 451 study in rats did not show any carcinogenic potential of nickel sulphate following oral administration. A summary document on this topic can be found in the attached document entitled, " Background-Oral Carcinogenicity for all Nickel Compounds" (Section 7.7 of IUCLID) and inAppendix B6of this CSR.

INHALATION: The most robust and environmentally relevant carcinogenicity study for NiO was conducted as part of a National Toxicology Program study on the toxicity and carcinogenicity of NiSO₄, Ni₃S₂and NiO (Dunnick et al. 1995). Following inhalation of NiO for up to two years (6 hr/d, 5 d/wk, two exposure levels), the authors characterized the evidence for lung tumor formation in rats as “some” as opposed to “no” or “clear. ” In mice, the authors characterized the evidence for NiO carcinogenicity in the lung as “equivocal.” Taken together the epidemiological and animal data suggest that at least some forms of nickel oxide can be carcinogenic to the respiratory tract of humans after inhalation. 

DERMAL: Dermal absorption to Ni oxides is very low (<1%). As oral exposure to nickel sulphate resulting in highest systemic bioavailability does not show any carcinogenic potential, there are good reasons to assume that cancer is not a relevant end-point with respect to dermal exposure either.

Value used for CSA (route: oral):

NOAEL: 11 mg Ni/kg bw/day Ni sulphate hexahydrate

Value used for CSA (route: inhalation):

NOAEC: 0.5 mg Ni/m³(Dunnick et al. 1995); and0.1 mg Ni/m³inhalable as the practical threshold for lung cancer (Oller et al., 2014)